NYKODE TOLERANCE NORWAY AS
934454618ActivePioneering immunotherapy platform unlocking future medicine for serious diseases.
Yleiskatsaus
- Tuntematon
- Työntekijät
- Tuntematon
- Liikevaihto
- 2024
- Perustettu
Avainpäättäjät
Michael Engsig
Chief Executive Officer
Agnete B. Fredriksen
Chief Scientific Officer & Business Development
Harald Gurvin
Chief Financial Officer
Louise Stubbe
Chief Legal Officer
Kuvaus
Nykode Therapeutics ASA is a biotechnology company dedicated to advancing human health through innovative medical science. The core of their operation is the proprietary Vaccibody molecule, which forms an unrivalled modular technology platform. This platform is designed to induce fast, strong, and l...
Tunnisteet
Avainsanat
Teknologiat
Yritystiedot
- Toimiala
- Tuntematon
- Oikeudellinen muoto
- Aksjeselskap
- ALV-numero
- Tuntematon
Päättäjät
4 yhteystietoa FunnelfeedrissäMichael Engsig
Chief Executive Officer
Agnete B. Fredriksen
Chief Scientific Officer & Business Development
Harald Gurvin
Chief Financial Officer
Louise Stubbe
Chief Legal Officer
Samankaltaiset yritykset
20 samankaltaista yritystä FunnelfeedrissäINCYTE BIOSCIENCES NORWAY AS
Global biopharmaceutical company developing innovative medicines for patients.
CELLMOVER AS
6 työntekijätPre-clinical immunotherapy company optimizing immune cell targeting for cancer.
ROCHE DIAGNOSTICS NORGE AS
100 työntekijätGlobal leader in pharmaceuticals and diagnostics driving personalized medicine.
ROCHE NORGE AS
46 työntekijätGlobal leader pioneering personalized medicine through pharmaceuticals and diagnostics.
Oncotech Nordic AB
0 työntekijätDeveloping AI diagnostics and immunotherapy to conquer global cancer.
Selaa lisää
Kysymyksiä yrityksestä NYKODE TOLERANCE NORWAY AS
Haluatko nähdä Funnelfeedrin toiminnassa?
Varaa ilmainen demo ja tutustu siihen, miten Funnelfeedr auttaa sinua löytämään ja konvertoimaan ihanteelliset asiakkaasi.
Varaa demo